Spatial intra‐tumour heterogeneity in acquired resistance to targeted therapy complicates the use of PDX models for co‐clinical cancer studies

Publisher： John Wiley & Sons Inc

E-ISSN： 1757-4684|7|9|1087-1089

ISSN： 1757-4676

Source： EMBO Molecular Medicine, Vol.7, Iss.9, 2015-09, pp. : 1087-1089

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Clinical experiences with molecular targeted therapy in lung cancer in China

By  

Thoracic Cancer, Vol. 6, Iss. 4, 2015-07 ,pp. : 379-384

John Wiley & Sons Inc

Access to resources Recommend Favorite

Intra‐ and inter‐tumor heterogeneity in a vemurafenib‐resistant melanoma patient and derived xenografts

By  

EMBO Molecular Medicine, Vol. 7, Iss. 9, 2015-09 ,pp. : 1104-1118

John Wiley & Sons Inc

Access to resources Recommend Favorite

Differences in skeletal muscle loss caused by cytotoxic chemotherapy and molecular targeted therapy in patients with advanced non‐small cell lung cancer

By  

Thoracic Cancer, Vol. 9, Iss. 1, 2018-01 ,pp. : 99-104

John Wiley & Sons Inc

Access to resources Recommend Favorite

Villages in the City: Spatial and Temporal Heterogeneity in Rurality and Urbanity in Bangalore, India

By Nagendra Harini   Unnikrishnan Hita   Sen Sreerupa  

Land, Vol. 3, Iss. 1, 2013-12 ,pp. : 1-18

MDPI

Access to resources Recommend Favorite

Spatial Preference Heterogeneity for Integrated River Basin Management: The Case of the Shiyang River Basin, China

By Aregay Fanus Asefaw   Yao Liuyang   Zhao Minjuan  

Sustainability, Vol. 8, Iss. 10, 2016-09 ,pp. : 970-970

MDPI

Access to resources Recommend Favorite